Noninvasive coronary computed tomographic angiography (CTA) can be used to evaluate the effectiveness of a metal-free bioabsorbable scaffold, according to a subanalysis of the ABSORB trial published ...

Please provide your email address to receive an email when new articles are posted on . In a pooled analysis of three single-center studies, a bioresorbable scaffold was associated with high rates of ...

Please provide your email address to receive an email when new articles are posted on . A novel bioresorbable scaffold was safe at 6 months in a first-in-human study in patients with stenosis in the ...

KYOTO, JAPAN — The risk of stent/scaffold thrombosis (ST) was higher through 2 years of follow-up with the Absorb GT1 bioabsorbable vascular scaffold (BVS) (Abbott Vascular) compared with ...

New York, May 07, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Bioabsorbable Stent/Bioresorbable Scaffold Industry" - https ...

FRANKLIN LAKES, N.J., March 20, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the first patient treated in an ...

PARIS, France—Two novel drug-eluting stents (DES) with bioresorbable scaffolds made promising debuts in separate first-in-man studies presented at EuroPCR 2012 on Wednesday, May 16. Both devices ...

In recent years, transcatheter intervention techniques have emerged as a promising alternative for the closure of perimembranous ventricular septal defect (VSD). The advancements in trancatheter VSD ...

MINNEAPOLIS, MN — With a clear eye toward its competition's unenviable position, Boston Scientific has decided to stop development of its bioabsorbable vascular scaffold, Renuvia. The decision to halt ...